ArticleJPRAS open2025
Rare presentation and resection of giant cell tumor invading the middle ear and skull base: A case report.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant cell tumors (GCTs) are common benign bone tumors found in young adults, frequently occurring in the long bones but rarely in the skull. Although considered benign, GCTs have the potential to be aggressive, destroying surrounding tissue. Here, we present the unusual case of a patient with a GCT of the middle ear and skull base. A 19-year-old male with an extensive giant cell tumor underwent surgical resection by a multidisciplinary team consisting of otolaryngology, neurosurgery, and plastic and reconstructive surgery. The mass was grossly resected, and a cervicofacial flap allowed for reconstruction with optimal cosmesis, a procedure not described for GCTs. This approach allowed for excellent wound healing without tumor recurrence. Gross total resection remains the most effective treatment for GCTs, minimizing radiation exposure and recurrence risk. However, an optimal surgical approach for skull GCTs has yet to be described. Skull-base GCTs present a challenge due to their complex anatomy and neurovascular elements. Further, the high rates of local recurrence make gross resection the goal of treatment, though this is difficult to achieve. The present case was successfully managed by extensive multidisciplinary surgical resection, highlighting the necessity of collaborative effects to achieve gross total resection and positive aesthetic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.